Home > Financial Ratios > CONCORD BIOTECH

CONCORD BIOTECH
Core EBITDA Growth

    Back to All Ratios
CONCORD BIOTECH is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for CONCORD BIOTECH
Please provide your vote to see the results

CONCORD BIOTECH Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) 21.3829.11-12.9944.86-

What is the latest Core EBITDA Growth ratio of CONCORD BIOTECH ?

The latest Core EBITDA Growth ratio of CONCORD BIOTECH is 21.38 based on Mar2024 Consolidated results.
Year Core EBITDA Growth
Mar202421.38
Mar202329.11
Mar2022-12.99
Mar202144.86
Mar2020-

How is Core EBITDA Growth of CONCORD BIOTECH Trending?

Years Core EBITDA Growth % Change
Mar2024 21.38
-26.55
Mar2023 29.11
Positive
Mar2022 -12.99
Negative
Mar2021 44.86
0
Mar2020 0 -

Other Financial Ratios of CONCORD BIOTECH


Compare Core EBITDA Growth ratio of peers of CONCORD BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CONCORD BIOTECH ₹17,082.2 Cr -7.5% -8.6% 10.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹383,570.0 Cr -6.5% -4.7% -5.1% Stock Analytics
DIVIS LABORATORIES ₹162,808.0 Cr -7.1% -11.5% 32.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹121,734.0 Cr -5.8% 6.1% 13.3% Stock Analytics
CIPLA ₹120,468.0 Cr -4.3% -0.1% -1% Stock Analytics
DR REDDYS LABORATORIES ₹100,212.0 Cr -5.8% -6.8% -11% Stock Analytics


CONCORD BIOTECH Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
CONCORD BIOTECH

-7.5%

-8.6%

10.2%

SENSEX

-0.7%

-3.7%

2.4%


You may also like the below Video Courses